These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 28934791)

  • 1. A Practical Guide for Treatment of Pain in Patients with Systemic Mast Cell Activation Disease.
    Wirz S; Molderings GJ
    Pain Physician; 2017 Sep; 20(6):E849-E861. PubMed ID: 28934791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological treatment options for mast cell activation disease.
    Molderings GJ; Haenisch B; Brettner S; Homann J; Menzen M; Dumoulin FL; Panse J; Butterfield J; Afrin LB
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Jul; 389(7):671-94. PubMed ID: 27132234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular symptoms in patients with systemic mast cell activation disease.
    Kolck UW; Haenisch B; Molderings GJ
    Transl Res; 2016 Aug; 174():23-32.e1. PubMed ID: 26775802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Surgical interventions in patients with systemic mast cell activation disease : Recommendations for perioperative management].
    Sido B; Homann J; Hertfelder HJ; Zienkiewicz T; Christians KP; Schablin P; Mücke M; Molderings GJ
    Chirurg; 2019 Jul; 90(7):548-556. PubMed ID: 30874862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mast cell activation disease: An underappreciated cause of neurologic and psychiatric symptoms and diseases.
    Afrin LB; Pöhlau D; Raithel M; Haenisch B; Dumoulin FL; Homann J; Mauer UM; Harzer S; Molderings GJ
    Brain Behav Immun; 2015 Nov; 50():314-321. PubMed ID: 26162709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Often seen, rarely recognized: mast cell activation disease--a guide to diagnosis and therapeutic options.
    Afrin LB; Butterfield JH; Raithel M; Molderings GJ
    Ann Med; 2016; 48(3):190-201. PubMed ID: 27012973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mast Cell Activation Disease and Microbiotic Interactions.
    Afrin LB; Khoruts A
    Clin Ther; 2015 May; 37(5):941-53. PubMed ID: 25773459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial occurrence of systemic mast cell activation disease.
    Molderings GJ; Haenisch B; Bogdanow M; Fimmers R; Nöthen MM
    PLoS One; 2013; 8(9):e76241. PubMed ID: 24098785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options.
    Molderings GJ; Brettner S; Homann J; Afrin LB
    J Hematol Oncol; 2011 Mar; 4():10. PubMed ID: 21418662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The genetic basis of mast cell activation disease - looking through a glass darkly.
    Molderings GJ
    Crit Rev Oncol Hematol; 2015 Feb; 93(2):75-89. PubMed ID: 25305106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms.
    Alvarez-Twose I; González de Olano D; Sánchez-Muñoz L; Matito A; Esteban-López MI; Vega A; Mateo MB; Alonso Díaz de Durana MD; de la Hoz B; Del Pozo Gil MD; Caballero T; Rosado A; Sánchez Matas I; Teodósio C; Jara-Acevedo M; Mollejo M; García-Montero A; Orfao A; Escribano L
    J Allergy Clin Immunol; 2010 Jun; 125(6):1269-1278.e2. PubMed ID: 20434205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Burning mouth syndrome and mast cell activation disorder.
    Afrin LB
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Apr; 111(4):465-72. PubMed ID: 21420635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for contribution of epigenetic mechanisms in the pathogenesis of systemic mast cell activation disease.
    Haenisch B; Fröhlich H; Herms S; Molderings GJ
    Immunogenetics; 2014 May; 66(5):287-97. PubMed ID: 24622794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandin D2-supplemented "functional eicosanoid testing and typing" assay with peripheral blood leukocytes as a new tool in the diagnosis of systemic mast cell activation disease: an explorative diagnostic study.
    Schäfer D; Dreßen P; Brettner S; Rath NF; Molderings GJ; Jensen K; Ziemann C
    J Transl Med; 2014 Aug; 12():213. PubMed ID: 25113638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Guidelines for the diagnosis, treatment and management of mastocytosis].
    De la Hoz B; González de Olano D; Alvarez I; Sánchez L; Núñez R; Sánchez I; Escribano L
    An Sist Sanit Navar; 2008; 31(1):11-32. PubMed ID: 18496577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transgenerational transmission of systemic mast cell activation disease-genetic and epigenetic features.
    Molderings GJ
    Transl Res; 2016 Aug; 174():86-97. PubMed ID: 26880691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunology and clinical manifestations of non-clonal mast cell activation syndrome.
    Cardet JC; Castells MC; Hamilton MJ
    Curr Allergy Asthma Rep; 2013 Feb; 13(1):10-8. PubMed ID: 23212667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mast cell activation syndromes presenting as anaphylaxis.
    Akin C
    Immunol Allergy Clin North Am; 2015 May; 35(2):277-85. PubMed ID: 25841551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical care management of systemic mastocytosis: when every wasp is a killer bee.
    van der Weide HY; van Westerloo DJ; van den Bergh WM
    Crit Care; 2015 Jun; 19(1):238. PubMed ID: 26036415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Vulvar oedema revealing systemic mastocytosis].
    Deveza E; Locatelli F; Girardin M; Valmary-Degano S; Daguindau E; Aubin F; Humbert P; Pelletier F
    Ann Dermatol Venereol; 2015 Nov; 142(11):685-9. PubMed ID: 26003033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.